Nijmegen, Netherlands

Alan Edward Rowan

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2023

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Alan Edward Rowan: Innovator in Biomimetic Networks and Immunomodulatory Constructs

Introduction

Alan Edward Rowan is a distinguished inventor based in Nijmegen, Netherlands. He has made significant contributions to the field of polymer science, particularly in the development of biomimetic networks and immunomodulatory protein constructs. With a total of 6 patents, his work has implications for both therapeutic and diagnostic applications.

Latest Patents

Rowan's latest patents include innovative technologies such as "Biomimetic networks comprising polyisocyanopeptide hydrogels." This invention describes a polymer hydrogel formed through the crosslinking reaction of specific polymeric units and water, with precise parameters for optimal performance. Another notable patent is "Immunomodulatory protein constructs with a helical polymeric backbone," which details constructs suitable for administration in immunotherapy, particularly for cancer treatment and other immunological applications.

Career Highlights

Throughout his career, Rowan has been associated with several prestigious institutions, including Radboud University Nijmegen and Stichting Katholieke Universiteit. His research has not only advanced the understanding of polymeric materials but has also opened new avenues for medical applications.

Collaborations

Rowan has collaborated with notable colleagues such as Roeland Johannes Maria Nolte and Jeroen Johannes Lambertus Maria Cornelissen, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

Alan Edward Rowan's work exemplifies the intersection of science and innovation, particularly in the realm of biomaterials and immunotherapy. His contributions continue to influence the development of new therapeutic strategies and materials.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…